Zoetis Soars On News Of Ackman Stake

It was reported Tuesday that activist investor Bill Ackman has accumulated a "roughly $2 billion stake" in Zoetis Inc ZTS.

The stock spiked on the news, soaring nearly 10 percent.

According to the report, Ackman “could push the animal-health company to sell itself to a
 large drug maker like Valeant Pharmaceuticals International Inc.”

“Mr. Ackman's Pershing Square Capital Management LP has built the stake, which amounts to roughly 10 percent of Zoetis, with fellow hedge fund Sachem Head Capital Management LP,” according to sources familiar with the developments.

A Dow Jones report noted that a “spokesman for Florham Park, N.J.-based Zoetis, which has a market value of about $20 billion, said the company got a call from Mr. Ackman regarding
the investment, but declined to comment on it.”

Zoetis closed at $43.72, up 8.8 percent.

Market News and Data brought to you by Benzinga APIs
Posted In: NewsDow JonesPershing SquareSachem Head Capital
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...